Skip to content

Clinical trials

Central Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Clear all

381 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20052
20066
20076
200810
200910
201017
201116
20129
201312
201419
201513
201615
201721
201819
201915
202023
202129
202226
202327
202423
202525
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed191
Recruiting66
Unknown status33
Terminated29
Active, not recruiting18
Not yet recruiting18
Withdrawn14
Enrolling by invitation8
No longer available2
Suspended1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)6
Eli Lilly and Company5
M.D. Anderson Cancer Center5
Novartis5
Tammie L. S. Benzinger, MD, PhD5
AbbVie4
Bracco Diagnostics, Inc4
Danish Headache Center4
FORUM Pharmaceuticals Inc4
GlaxoSmithKline4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases381
Brain Diseases219
Nervous System Diseases208
Neurodegenerative Diseases97
Stroke80
Cerebrovascular Disorders72
Alzheimer Disease63
Dementia60
Movement Disorders56
Vascular Diseases56

Trials

Showing 1 to 25 of 381. Each trial links to its page on Pharma Observatory.

281 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.